Indinavir is a protease inhibitor belonging to the class of antiretroviral agents used in the treatment of HIV infection by inhibiting the viral protease enzyme to prevent the maturation of infectious… Read more


![Chemical structure of (S)-1-{[(2S ,4R )-4-Benzyl-5-oxotetrahydrofuran-2-yl]methyl}-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F913293-57-9-S-1-2S-4R-4-Benzyl-5-oxotetrahydrofuran-2-ylmethyl-N-tert-butyl-4-pyridin-3-ylmethylpiperazine-2-carboxamide.png&w=3840&q=75)





![Chemical structure of 2-Benzyl-1-(2,2-dimethyl-8,8α-dihydro-3α,H-indeno[1,2-d]oxazol-3yl)-3-oxiranyl-propan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F158512-24-4-2-Benzyl-1-22-dimethyl-88-dihydro-3H-indeno12-doxazol-3yl-3-oxiranyl-propan-1-one.png&w=3840&q=75)


Indinavir is a protease inhibitor belonging to the class of antiretroviral agents used in the treatment of HIV infection by inhibiting the viral protease enzyme to prevent the maturation of infectious viral particles. To support rigorous analytical testing and quality control, this category provides a comprehensive range of indinavir reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and relevant metabolites. Laboratories utilize these materials for impurity profiling, ensuring accurate identification and quantification of potential degradation products or synthesis-related impurities. Additionally, the inclusion of stable isotope labelled compounds provides essential internal standards for mass spectrometry-based assays, facilitating precise method validation and pharmacokinetic studies. Whether conducting routine quality control or complex stability testing, these analytical standards are vital for maintaining the integrity and regulatory compliance of pharmaceutical workflows throughout the drug's lifecycle.